Please assess the completion status of the following clinical trial:

Trial Title: TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* o Pregnant women attending for elective CS.~  * Women on antenatal anticoagulation ( LMWH , UFH , Fondaparinux ) for conditions such as : Prosthetic Valve , DVT , Pulmonary embolism , Dural sinus thrombosis , AF.~ * Pregnant Women with indication for postnatal warfarin anticoagulation( Prosthetic Valve , DVT , Dural Sinus Thrombosis , AF , Pulmonary embolism )~ * Age between 20-40 years.~ * Pregnancies between 37 and 39 weeks~ * BMI between (18.5 - 30.0)~Exclusion Criteria:~* o Pregnancy with risk of obstetric hemorrhage such as abnormally invasive placenta, placenta previa, placental abruption.~  * Women with Renal and Hepatic failure~ * Women with bleeding diathesis for reasons other than warfarin anticoagulation therapy~ * Women with known allergy to Tranexamic acid~ * Anemia Hb below 8g/dl

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Gelatin Sponges soaked with TXA (Type: EXPERIMENTAL): 21 patients will have 2 pieces of Gelatin Sponges (SURGISPON®; AEGIS LIFESCIENCES, India) (Size, 40 cm2) soaked in Tranexamic acid (Kapron, Amoun Pharmaceuticals SAE, Egypt. 5ml Amp, 100mg /1ml) each sponge will be soaked with one ampoule and applied between the anterior rectus sheath and the rectus abdominis muscle, one sponge on each muscle.
- Gelatin Sponges (Type: EXPERIMENTAL): 2 Gelatin Sponges (SURGISPON®; AEGIS LIFESCIENCES, India) (Size, 40 cm2)
- NO SPONGE (Type: NO_INTERVENTION): 21 patients will have no sponge inserted 10 ml of saline

Based on this trial design, predict the completion outcome and termination type (if applicable).